Melinta Therapeutics (MLNT)

Quick facts

Marketed products

• Baxdela · Infectious Disease
  Baxdela works by blocking bacterial enzymes that replicate DNA.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Melinta Therapeutics portfolio CI brief
• Melinta Therapeutics pipeline updates RSS